Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1675 USD | -1.18% | -9.26% | +19.64% |
05-20 | Elite Pharmaceuticals Receives Fda Approval for Generic Methotrexate | CI |
02-15 | Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 |